In the US, Pentostatin (pentostatin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Hairy Cell Leukemia.
US matches:
- Pentostatin
- Pentostatin Intravenous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XX08
CAS registry number (Chemical Abstracts Service)
0053910-25-1
Chemical Formula
C11-H16-N4-O4
Molecular Weight
268
Therapeutic Category
Antineoplastic antibacterial
Chemical Names
2'-Deoxycoformycin
Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-ß-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-
Foreign Names
- Pentostatinum (Latin)
- Pentostatin (German)
- Pentostatine (French)
- Pentostatina (Spanish)
Generic Names
- Pentostatin (OS: JAN, USAN, BAN)
- Pentostatine (OS: DCF)
- 2'-dCF (IS)
- CI 825 (IS: Parke-Davis)
- Co-V (IS)
- Co-vidarabine (IS)
- DCF (IS)
- NSC 218321 (IS)
- PD-ADI (IS)
Brand Names
- Coforin
Nippon Kayaku, Japan
- Nipent
Hospira, France; Hospira, United Kingdom; Hospira, Greece; Hospira, Italy; Hospira, United States; IFET, Greece; Mayne, Spain; SuperGen, United States
- Pentostatin
Wyeth, New Zealand
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and
International Nonproprietary Names.